Coronavirus and Telehealth Support Groups

Patients Can Gain Support Remotely from Other Patients and Doctors Associated with the XRHealth Telehealth Clinics

XRHealth clinics note they are now certified in Boston, Connecticut, Florida, Michigan, Washington D.C., Delaware, California, New York, Texas, North Carolina, and many others and are covered by Medicare and most major insurance providers.

Due to the immediate need of this technology because of social distancing in response to the spread of coronavirus, XRHealth will make the technology available sooner than originally expected and it will officially be available to the public on April 1st.

XRHealth support groups are tailored for patients with the following conditions: Multiple Sclerosis, Parkinsons, breast cancer, menopause, an injury that effected motor function, anxiety, chronic pain, fibromyalgia, substance abuse, post-stroke rehabilitation, brain injury and there will also be general support group for the elderly population that is most impacted by the coronavirus.

The ability for patients to connect with each other in VR and with a group moderator is powered by Foretell Reality, a subsidiary company of The Glimpse Group, Inc. and a platform provider of VR environments and toolsets that facilitate authentic human interactions between remote individuals and groups in life-like, secure and virtual spaces.

“Virtual Reality is providing healing opportunities to patients that once could not leave their homes and were suffering in silence,” says Eran Orr, CEO of XRHealth. “Virtual Reality capabilities offer support and assistance to patients around the world, in the comfort of their home. This is especially rewarding to patients that are immobile or unable to engage with a group in-person. It also provides high-quality care from leading doctors that patients might otherwise not have had access to.
One of the most troubling issues during the coronavirus crisis is that people are forced to be isolated and we believe that virtual support groups in VR will be able to ease the loneliness and isolation.”

Dror Goldberg, General Manager of Foretell Realty added: “VR brings people together into the same immersive environment, fostering intimate interaction in powerful ways that are not possible via other mediums of remote communication. Specifically for group therapy, studies have shown that self-representation in VR through avatars helps patients overcome initial hesitation and facilitates the sharing of personal information and emotions.”

SourceXRHealth

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”